Get alerted on the PharmaSources E-Newsletter and Pharma Sources Insight E-Compilation!
Note: You can unsubscribe from the alerts at any time.
Advertising

Pfizer announces positive top-line results from JADE TEEN trial of abrocitinib in adolescents with moderate-to-severe atopic dermatitis

pharmaceutical-business-reviewJune 17, 2020

Tag: Pfizer , JADE TEEN , abrocitinib , JAK1

PharmaSources Customer Service